STAT3 mainly acts as a signal transducer of IL-6 family cytokines and transcriptionally activates specific target genes. STAT3 has also been demonstrated to mediate cellular transformation and is found in numerous cancers. Endocrine-Disrupting Chemicals (EDCs) are a diverse group of chemicals that bind to estrogen receptors (ERs), mimic estrogenic actions, and may have adverse effects on human health. In our previous study, we demonstrated that estrogens suppressed the STAT3-mediated transcription activity through ERs. In this study, we examined the effects of EDCs on STAT3-mediated signaling through ERs. Surprisingly, some of EDCs enhanced STAT3-mediated transcription activity through ERs. This finding strongly suggests that EDCs may play an important role in the endocrine functions by mimicking cytokine activity by stimulating STAT3 actions through ERs.
INTRODUCTION
In addition to the endogenous hormone estradiol (17β-estradiol; E2), estrogen receptor (ER) activity can be modulated by chemicals in the environment termed endocrine-disrupting chemicals (EDCs) or xenoestrogens, which include natural plant compounds (phytoestrogens) and industrial byproducts (industrial estrogens). Recently, there has been increasing awareness and concern about the endocrine-disrupting effects of these chemicals and their impact on humans and animals (1, 2, 3) . Although the molecular mechanisms of EDCs are not well understood, it is clear that many of these chemicals function by binding ERs and blocking estrogen action (4) . In addition to their potential antagonist activities, EDCs are also known to induce activating conformational changes in ERs that enable the receptors to interact with co-activators and to activate target gene transcription (5, 6, 7) .
It has been actually shown that the in vivo effects of EDCs such as Bisphenol A mimic those of 17β-estradiol (E2), including the vaginal cornification (8) , growth and differentiation of the mammary gland (9) , a decreased cholesterol level in serum (10) , an increased prolactin level (11) , and an increased c-fos mRNA level in the uterus (8) , suggesting that EDCs have enough potential to alter reproductive function and endocrine system in vivo. However, we do not know whether the EDCs can modify other cellular signaling such as growth factors or cytokines.
One member of the STAT family of proteins is STAT3, which is mainly activated by IL-6 family of cytokines including Leukemia inhibitory factor (LIF) and Leptin (12) .
Like other members of the STAT family, STAT3 is tyrosine-phosphorylated by Jak kinases, then forms a dimer and translocates into the nucleus to activate target genes (13, 14) . It has been shown that the activated STAT3 can mediate cellular transformation (15, 16, 17) and is found in numerous cancers, including prostate and breast cancer (17) .
Furthermore, STAT3 has been recently shown to act as an oncoprotein (15). Human embryonic kidney carcinoma cell line, 293T cells were transfected in DMEM containing 1% FCS by the standard calcium precipitation protocol (23) . Human hepatoma cell line Hep3B was maintained in DMEM containing 10% FCS (24) . Before stimulation, the cells were cultured for 12 h in DMEM containing 1% FCS followed by treatment with or without LIF and/or E2 or EDCs. Hep3B cells were transfected by using FuGENE6 (Roche Diagnostics GmbH, Mannheim, Germany) following manufacturer's instructions. Luciferase assay was performed as described (23) . The cells were harvested 48 h after transfection and lysed in 100 µl of PicaGene Reporter Lysis Buffer (Toyo Ink, Tokyo, Japan) and assayed for luciferase and β-galactosidase 6 activities according to the manufacturer's instructions. Luciferase activities were normalized to the β-galactosidase activities. During EDCs' stimulation, cell viability did not changed, when we monitored by Cell Counting Kit-8 (Wako Chemicals, Tokyo, Japan). Three or more independent experiments were carried out for each assay.
Immunoprecipitation and immunoblotting.
Immunoprecipitation and Western blotting were performed as described previously (23) .
Briefly, the transfected 293T cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 0.3 M NaCl, containing 1% NP-40, 1mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride and 10 µg/ml each of aprotinin, pepstatin and leupeptin).
Aliquots of cell lysates were resolved on 5-20% SDS-PAGE and transferred to Immobilon membrane (Millipore, Bedford, MA). The membranes were then probed with each antibody as indicated. Immunoreactive proteins were visualized using an enhanced chemiluminescence detection system (Amersham Pharmacia Biotech).
RESULTS AND DISCUSSION

Cross-talk between of EDCs and STAT3-mediated signaling through ERs.
We previously demonstrated that estrogens inhibited STAT3-mediated signaling pathway through estrogen recptors (ERs) (18) . We then examined whether EDCs has any inhibitory effect on STAT3-mediated signaling through ERs, because it is clearly shown that many of EDCs function by binding ERs and blocking estrogen access (4) .
EDCs is also demonstrated to induce activating conformational changes in ERs that enable the receptors to interact with co-activators and to activate target gene transcription (5, 6, 7) To first examine the EDC-mediated signaling through ERs, we carried out transient transfection experiments in 293T cells. ER activity by EDCs was monitored by using Vit-LUC in which two copies of an estrogen response response element (ERE) drive expression of the LUC gene (18) . As shown in for ERα were stimulated with leukemia inhibitory factor (LIF) (25) in the absence or presence of E2 or EDCs. As shown in Fig. 1B , STAT3-LUC activity was stimulated by LIF, whereas E2 or each EDC alone did not change this activity. In the presence of ERα and LIF, E2 suppressed STAT3-LUC activity in a dose-dependent fashion as we described previously (18) . Genistein and Nonylphenol did not alter LIF-induced STAT3-LUC activity. Interestingly, Bisphenol A, Methoxychlor, α-Endosulfan significantly enhanced LIF-induced STAT3-LUC activity.
We next examined if EDCs has similar effects on STAT3-mediated signaling through the other major ER isoform, ERβ (26) , in an analogous experiment. As shown in Fig.   1C , LIF-stimulated STAT3-LUC activity was enhanced by Methoxychlor and α-Endosulfan in the presence of ERβ, similar to that observed with ERα. These data suggest that both ER isotypes may be involved in enhancement of STAT3-mediated signaling by EDCs.
To examine the cross-talk between EDCs and STAT3-mediated signaling pathway under more physiological conditions through endogenous ER proteins, we first utilized a LIF-responsive, ER-positive hepatoma cell line, Hep3B (27) , and the transient transfection assay. Hep3B cells were transfected with STAT3-LUC and treated with LIF and/or E2 or EDCs and LUC activities were determined (Fig. 1D) . When cells were treated with both LIF and E2, STAT3-LUC activation was decreased by 40-50% compared with the activation by LIF alone. In contrast, Bisphenol A, Methoxychlor, α-Endosulfan enhanced LIF-induced STAT3-LUC activity more than those observed in 293T cells.
A dominant negative STAT3 can reverse the enhanced effect of EDCs on STAT3 activation.
We next assessed whether the observed effects were mediated through STAT3 or some other intermediary factors, we used a dominant negative form of STAT3 (DN-STAT3) (20) . A DN-STAT3 significantly inhibited IL-6-or LIF-induced STAT3-LUC expression in a dose-dependent fashion in 293T cells as described previously (27) . As shown in Fig. 2A, a DN (Fig. 2B) , whereas an inhibitory effect of ER/E2 on STAT3 activation was reversed by Tamoxifen as described previously (18) . These results indicate that the enhanced effect of EDCs on STAT3 activation in 293T cells is mediated by ERα.
Effects of EDCs on LIF-induced phosphorylation of STAT3
We next examined whether EDC treatment has any effect on immediate early STAT3 activation by LIF in 293T cells. We then assessed changes in tyrosine-phosphorylation of STAT3 in 293T cells. To that end, 293T cells were transfected with ERα and either left untreated or treated with LIF, LIF plus E2 or EDCs, and their cell extracts were prepared and subjected to Western blot analysis with an anti-phospho STAT3 (Tyr705) antibody. As shown in Fig. 3A , tyrosine-phosphorylation of STAT3 by LIF had no alteration even in the presence of E2 or EDCs.
We also examined Ser727-phosphorylation of STAT3 using an anti-phospho STAT3 (Ser727) antibody.
Similarly, serine phosphorylation of STAT3 showed no alteration by EDCs (Fig. 3A) .
These data show that EDC treatment results in no alteration of STAT3 phosphorylation 10 in 293T cells.
Involvement of MAP kinase signaling in EDC-mediated enhancement of STAT3 activation.
One of the possible mechanisms that are consistent with the data described above is that there is an alternative pathway to activate STAT3 like MAP kinase (MAPK) signaling.
We tested this possibility by reporter assays to monitor other signaling pathways. We were enhanced by EDCs (Fig. 4A ). These data suggest that the EDC treatment resulted in the induction and activation of MAPK in 293T and Hep3B cells. We finally tested the effect of an MAPK inhibitor on the enhancement of STAT3 activation by EDCs.
Enhanced effect of ER/EDCs on STAT3 activation was partly inhibited in a dose-dependent manner by a MAPK inhibitor, PD98059, when cells were treated with increasing concentrations of PD98059 (Fig. 4B) . These results suggest that the enhanced effect of EDCs on STAT3 activation is partly mediated by MAPK signaling pathway.
Concluding remarks
We have shown here that the EDCs enhance STAT3-mediated signaling through ERs. Moreover, most of them can easily access the human body by ingestion or absorption through the skin and mucosal membranes, since those are lipophilic. EDCs have been also suggested to disrupt the internal signaling network that regulates reproductive development and function in animals and humans. In males, environmental exposure to EDCs has been associated with a high incidence of reproductive tract problems such as cryptorchidism, decreased sperm count, hypospadias, and testicular cancer (28, 29, 30) .
Furthermore, the carcinogenic potential role of EDCs in development of breast cancer in women has been also discussed, but is still questionable (30, 31) .
Activation of STAT3 is required for cell transformation by oncogenic Src and by a constitutively active form of Go, a heterotrimeric G-protein subunit (15, 16). In addition, STAT3 is found to be active in several cancer including breast cancer and prostate cancer cells (17) . Furthermore, STAT3 has been recently shown to act as an oncoprotein (15). These results may suggest the possibility that enhancement of STAT3 activation by EDCs triggers STAT3-mediated oncogenesis.
In this study, we demonstrated that EDCs enhance cytokine signaling pathway through ERs. It is also noteworthy that MAPK signaling is involved in this effect of EDCs on cytokine signaling. This implies that EDCs-activated MAPK signaling may stimulate phosphorylation of STAT3 to activate, although we could not detect any enhancement of phosphorylation of STAT3. There may be also the possibility that some conformational change of ER by EDCs is involved in this effect of EDCs. Further work would be required to assess the detailed mechanisms of this cross-talk. This study also suggest that EDCs should be evaluated to determine whether they can be subdivided in separate classes of EDCs based on this novel function, which affects cytokine signaling.
This knowledge may provide new targets for the prevention of hormonal carcinogenesis or provide rationalization of the carcinogenic potential of EDCs. 
